Brief: Poolbeg Pharma PLC Announces Immunomodulator I Patent Opposition Withdrawal
19/09/2023 07:59
Sept 19 (Reuters) - Poolbeg Pharma PLC POLB.L :
* POOLBEG PHARMA PLC - IMMUNOMODULATOR I PATENT OPPOSITION
WITHDRAWAL
* POOLBEG PHARMA PLC - OPPOSITION TO ONE OF ITS EUROPEAN
PATENTS
(IMMUNOMODULATOR I) PREVIOUSLY FILED BY A THIRD PARTY IS TO BE
WITHDRAWN
Source text for Eikon: ID:nRSS8374Ma
Further company coverage: POLB.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Poolbeg Pharma
See all newsBrief: Poolbeg Pharma Says European Patent Granted For POLB 001 In CRS
PDMR Notification
Brief: Poolbeg Pharma Says FDA Feedback Broadly Aligned With Development Pathway For POLB 001
Brief: Poolbeg Pharma Announces Granted POLB 001 Cancer Immunotherapy-Induced CRS Patent In Canada
Annual Report & AGM Notice